about
Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseOutcomes of abdominal surgery in patients with liver cirrhosisSpontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liverMicrobiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Renal and Gastrointestinal Considerations in Joint Replacement Surgery.Alterations of Bacteroides sp., Neisseria sp., Actinomyces sp., and Streptococcus sp. populations in the oropharyngeal microbiome are associated with liver cirrhosis and pneumonia.Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation.Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus InfectionBloodstream infections in patients with liver cirrhosis.Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis.Influence of cirrhosis in cardiac surgery outcomes.Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.Detection of human polyomaviruses JC and BK in liver pretransplant patients.Liver Cirrhosis/Severe Fibrosis Is a Risk Factor for Anastomotic Leakage after Colorectal Surgery.Immune Dysfunction in Cirrhosis.Hepatic decompensation in the absence of obvious precipitants: the potential role of cytomegalovirus infection/reactivation.The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.Risk of liver cirrhosis in patients with tuberculosis: a nationwide cohort study.Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis.Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.Immune checkpoint receptors: homeostatic regulators of immunity.
P2860
Q26745984-080879ED-3C60-4395-8E3E-FBCCC72628B3Q26766070-C67F262C-9B4E-4069-ACE7-B6ACE5CF4E23Q27001540-4C5C9005-E084-4B62-A38F-8CFC793C8F37Q34647371-5577DF82-5B44-4E93-8DE6-92E1F1E5FEC7Q35207986-D08F8411-707C-4048-90EA-6C0DA8BA62F1Q35670994-39CEEEB6-653B-4E37-9951-B7A9FE9222A2Q36054086-879C5DAB-F671-47F3-B97F-835876078445Q36055483-9A168821-24AB-4457-A019-E1FE80D9A784Q36913304-95DC2BF1-D669-4CB8-B988-80D848841E92Q37206442-1BB94C10-3346-400D-BB74-A1B96756CBE5Q38443646-7B893627-6877-4D34-AD8D-06DB7D5F3C10Q38635623-D67642A2-7674-46C8-887C-3530B5F5CBA2Q39004168-75E2471A-9233-421E-8F3E-4A06A8CD6293Q39095799-2A6D6AD5-42A1-4B6F-91CC-F5408B50265DQ39308805-161D7540-41D0-431E-A060-0B72E13EF506Q39409484-17569A7E-E762-4661-A6AC-173783DCCDC8Q40265624-64D5FA56-588C-45F5-ABE5-D844F9897E80Q40274765-462A1189-0913-4543-B757-AE113325857EQ40302905-3CD4542E-7F55-4B71-BC65-06FE3E2630D2Q40363376-E81D1988-C581-4962-9FB0-62DA8B71DF3EQ42042373-AAA02C6E-830D-41FD-8618-E1342552EBD0Q42350834-3CB2D30D-FE5B-42F2-A0A7-3E5B6D461987Q50099829-AB76D980-B2C5-46B0-AD22-E1397DC6D2B6Q53685582-CD879459-D8E4-4ABC-ACE3-4A7092EEE8E6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune dysfunction in cirrhosis.
@en
type
label
Immune dysfunction in cirrhosis.
@en
prefLabel
Immune dysfunction in cirrhosis.
@en
P2860
P356
P1476
Immune dysfunction in cirrhosis.
@en
P2093
Maria Papp
Peter Antal-Szalmas
P2860
P304
P356
10.3748/WJG.V20.I10.2564
P407
P577
2014-03-01T00:00:00Z